Senseonics Holdings (SENS) Return on Capital Employed (2015 - 2026)
Senseonics Holdings' (SENS) quarterly Return on Capital Employed came in at 98.25% in Q1 2026, down 1322.0% year-on-year from 8.04% in Q1 2025, and down 56.35% on a QoQ basis from 62.84% in Q4 2025.
Senseonics Holdings (SENS) Return on Capital Employed (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of Return on Capital Employed data on file, last reported at 98.25% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 1322.0% year-over-year to 98.25% in Q1 2026; TTM through Mar 2026 was 98.25%, a 1322.0% decrease from a year earlier, with the FY2025 full-year figure at 76.78%, up 1622.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 98.25%, down from 62.84% in the prior quarter.
- Over the last five years, Return on Capital Employed for SENS reached as high as 37.66% in Q1 2022 and fell as low as 125.71% in Q4 2024.
- Historically, Return on Capital Employed has averaged 67.67% across 5 years, with a median of 58.66% in 2023.
- Across the five-year window, Return on Capital Employed plunged 6705 bps in 2024 and soared 6362 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 46.15% in 2022, then fell by 27 bps to 58.66% in 2023, then plunged by 114 bps to 125.71% in 2024, then soared by 50 bps to 62.84% in 2025, then sank by 56 bps to 98.25% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 98.25% in Q1 2026, 62.84% in Q4 2025, and 49.73% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn | -98.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.25% |
| Dec 31, 2025 | -62.84% |
| Sep 30, 2025 | -49.73% |
| Jun 30, 2025 | -62.45% |
| Mar 31, 2025 | -85.03% |
| Dec 31, 2024 | -125.71% |
| Sep 30, 2024 | -113.35% |
| Jun 30, 2024 | -85.83% |
| Mar 31, 2024 | -72.28% |
| Dec 31, 2023 | -58.66% |
| Sep 30, 2023 | -56.78% |
| Jun 30, 2023 | -54.26% |
| Mar 31, 2023 | -47.57% |
| Dec 31, 2022 | -46.15% |
| Sep 30, 2022 | -52.50% |
| Jun 30, 2022 | -41.38% |
| Mar 31, 2022 | -37.66% |
| Dec 31, 2021 | -29.96% |
| Sep 30, 2021 | -25.81% |
| Jun 30, 2021 | -25.56% |